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Introduction: Despite an increase in the number of cadaver donors and overall organ transplantations, the dramatic
increase in the waiting list makes it necessary to reconsider donor criteria. The authors wanted to examine whether
differences could exist in the function and/or morphology of transplanted kidneys originated from expanded criteria
donors (ECDs) and ideal donors 1 and 5 years after transplantation. Methods: Kidney function and histopathologic
ﬁndings were analyzed and compared 1 and 5 years after transplantation in 97 patients having ECD kidneys and in
178 patients who received ideal donor kidneys (IDK). Results: Serum creatinine level was signiﬁcantly higher
(p= 0.001) and estimated glomerular ﬁltration rate was signiﬁcantly lower (p= 0.003) in patients having ECD
kidneys as compared with those with IDK 5 years after transplantation. Morphological changes in the transplanted
kidneys, such as tubulitis (p= 0.025) and interstitial inﬂammation (p= 0.002), were signiﬁcantly more frequently
present in patients with ECD kidneys than in those with IDK 1 year after transplantation. Conclusion: Despite an
absence of differences in kidney function 1 year after kidney transplantation between patients having ECD and IDK,
morphological differences in the transplanted kidneys can be detected between the two groups of patients.
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Introduction
The incidence of end-stage renal failure is growing all over the world (4, 14). Two treatment
options are available: dialysis and kidney transplantation. Kidney transplantation provides
improved quality of life and long-term survival compared with dialyzed patients. Due to the
gradual increase in the number of patients on the transplant waiting list, expanding the criteria
regarding donors is required. Although most studies of expanded criteria donor (ECD) kidney
transplantation conﬁrm lower allograft survival rates and, generally, worse outcomes than
standard criteria donor kidneys, recipients of ECD kidneys generally have improved survival
compared with wait-listed dialysis patients, thus encouraging the pursuit of this type of
kidney transplantation.
There are ECD kidneys and ideal donor kidneys (IDK) in accordance with donor
criteria (9). The incidence of transplantation from older donors (>50 years of age) was
12.5% in 1995, this ratio increased to 25.3% in 2005 in Hungary (8, 10). Although there is
no clear consensus regarding the deﬁnition of ECDs and IDK, in case of donors above the
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age of 55 years, non-heart-beating donation (NHBD), cold ischemia time (CIT) above
36 h and donors having diabetes mellitus or hypertension for more than 10 years, the
kidney is considered to be ECD kidney (8, 13). International studies found that ECD
kidneys were not signiﬁcantly worse compared with IDK after the transplantation (7, 17).
Compared with dialysis, transplantation with ECD kidney is more cost-effective results in
better quality of life and long-term survival, therefore, expanding donor criteria is
indicated (8, 18).
The aim of this study was to evaluate the survival as well as functional and histopatho-
logical changes of ECDs and IDK. In accordance with previous studies, survival of “optimal”
donor grafts was better compared with that of ECD kidneys, although it is less established
whether there is any difference regarding function and/or morphology of ECDs and IDK 1
and 5 years after the transplantation.
Methods
In the Department of Surgery, University of Szeged, 275 patients were transplanted between
January 1, 2010 and December 31, 2015. About 97 kidneys were obtained from ECDs and
178 kidneys were IDK. NHBD was performed in two cases, CIT was more than 36 h in eight
cases, the donors had hypertension in 27 cases, and the donors were above the age of 55 in
60 cases in the ECD groups.
In this study, the gender and serum creatinine levels of the donors, the perfusion
solution, diuresis for 24 h before the removal of the organ, CIT, incidence of human
leukocyte antigen (HLA)-mismatch, cause of death of the donor, and the age of the donor
were examined. Functional and histopathological changes in the kidneys were examined 1
and 5 years after the transplantation in the two patient groups. Estimated glomerular ﬁltration
rate (eGFR) was calculated using the Cockroft–Gault formula.
Histopathological changes of the graft were examined 1 year after the transplantation
in 275 patients with kidney biopsy performed in accordance with protocol. Biopsy was
performed in case of all kidneys before the transplantation. Histological sample was
collected with a 16 G tru-cut-type needle. Sections were evaluated after standard histolog-
ical staining (hematoxylin and eosin, periodic acid Schiff, trichrome, and methenamine
silver) using a light microscope. Immunohistochemistry tests were performed with the
identiﬁcation of anti-HLA class II antibodies, complement 4d (C4d), C3, IgG, IgA, and
IgM. Histological changes were classiﬁed using the Banff score from Loupy et al. and
Banff Working Groups (5, 11).
The study was approved by the University of Szeged, Albert Szent-Györgyi Clinical
Center, Regional and Institutional Human Medical Biological Research Ethics Committee
(registration number: 17/2010). Patients received comprehensive information regarding the
study.
Results
Serum creatinine level of the donors was 94.6 ± 28.1 μmol/l in the ECD group and
90.8 ± 32.1 μmol/l in the IDK group ( p = 0.123). Cause of death of the donors and the
applied perfusion solutions were not signiﬁcantly different between the two groups
(Table I).
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Regarding graft function, we have concluded that 1 year after the transplantation, there
were no signiﬁcant differences between the ECD and IDK groups in serum creatinine levels
(p= 0.20) and eGFR values (p= 0.15). On the contrary, 5 years after the transplantation,
serum creatinine level (ECD: 252.3 ± 122.8; IDK: 171.4 ± 93.7 μmol/l; p= 0.001) and eGFR
(ECD: 39.9± 14.4; IDK: 54.5± 16.3; p= 0.003) were signiﬁcantly different between the two
patient groups (Table II).
Regarding morphological changes in the kidneys, the incidence of interstitial
inﬂammation (69% vs. 33%; p = 0.025) and tubulitis (64% vs. 40%; p = 0.014) was
signiﬁcantly increased in the ECD group compared with the IDK group 1 year after the
kidney transplantation. There was no signiﬁcant difference in the incidence of other
histological changes (such as arteriolar hyalinosis and glomerulitis) between the two
groups (Table III).
Table I. Donor data between the ECD and IDK groups
ECD (n= 97) IDK (n= 178)
p valueMean± SD Mean± SD
Donor gender (women/men) 42/55 82/96 0.281
Donor creatinine (μmol/l) 94.60± 28.10 90.83± 32.093 0.123
Last 24 h diuresis (h) 5.535± 2.405 5.689± 2.086 0.156
Cases of death Stroke 41 (42%) 92 (52%) 0.257
Subarachnoid bleeding 14 (14%) 33 (18%) 0.245
Trauma 17 (18%) 39 (22%) 0.067
Other 25 (26%) 14 (8%) 0.157
Perfusion solution Custodiol 61 (63%) 71 (40%) 0.267
Euro collins (EC) 27 (28%) 60 (34%) 0.138
Ultra viaspan (UW) 7 (7%) 41 (23%) 0.589
Histidine-tryptophan-
ketoglutarate (HTK)
2 (2%) 6 (3%) 0.316
SD: standard deviation; ECD: expanded criteria donor; IDK: ideal donor kidneys
Table II. Functional changes between the ECD and IDK groups
ECD IDK p value
1 year after kidney
transplantation
eGFR (ml/min/1.73 m2) 51.06± 18.52 53.75± 16.57 0.151
serum creatinine (μmol/l) 145.65± 63.88 132.78± 58.62 0.200
5 years after kidney
tranplatation
eGFR (ml/min/1.73 m2) 39.92± 14.49 54.54± 16.32 0.003
serum creatinine (μmol/l) 252.36± 122.83 171.45± 93.72 0.001
ECD: expanded criteria donor; IDK: ideal donor kidneys; eGFR: estimated glomerular ﬁltration rate
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Discussion
Due to changing donor demographics, excessive waiting times, and the increasing disparity
between organ supply and demand, the use of kidneys from ECDs has become generally
accepted and increasingly common (9). In this study, we followed up kidneys from ECDs and
IDK. The ratio of patients having kidney from ECDs was 35% between January 1, 2010 and
December 31, 2015. This ratio was only 12.5% in the 1990s. The increase in the number of
ECD kidneys is partly due to the expanding of donor criteria and the fact that the number
of patients in the waiting list has rapidly increased during the past few years. In the study of
Ojo et al. (8), the ratio of graftectomy was 35.9% in the ECD group, whereas 24.9% in the
IDK group ( p< 0.001). Gopalakrishnan and Gourabathini (4) found that the ratio of
graftectomy was 47% versus 25% in the same groups.
Like other research groups (7, 9, 16), we also found that 1 year after the transplantation,
serum creatinine and eGFR values were not signiﬁcantly different between the two groups.
On the other hand, 5 years after the transplantation, serum creatinine ( p= 0.001) and eGFR
( p= 0.003) were signiﬁcantly different between the two groups. Regarding histopathological
changes, the incidence of tubulitis and interstitial inﬂammation was signiﬁcantly different
1 year after the transplantation between patients transplanted with ECD and IDK. This
suggests that difference between morphological changes in the two groups occurs earlier than
that in functional changes.
Besides differences between the ECD and IDK groups, the gradually increasing transplan-
tation waiting lists necessitate expanding the donor criteria and the options for transplantation
(1–3, 6, 12, 15). Quality of life and long-term survival of patients receiving dialysis treatment are
worse compared with patients transplanted with ECD kidneys. ECD makes transplantation
available for more patients and enables improving the quality of life and long-term survival for
more patients. The transplantation of kidneys obtained from older donors fulﬁlling ECD
Table III. Banff score changes 1 year after kidney transplantation
ECD (n= 97) IDK (n= 178) p value
Glomerulitis 0 38 (39%) 127 (71%) 0.347
1–3 59 (61%) 51 (29%) 0.289
Intersitial
inﬂammation
0 30 (31%) 119 (67) 0.745
1–3 67 (69%)* 59 (33%) 0.025
Tubulitis 0 35 (36%) 108 (60%) 0.934
1–3 62 (64%)** 70 (40%) 0.014
Arteriola hyalinosis 0 62 (64%) 152 (85%) 0.297
1–3 35 (36%) 26 (15%) 0.528
Intimal arteritis 0 71 (73%) 114 (64%) 0.794
1–3 26 (27%) 64 (36%) 0.438
ECD: expanded criteria donor; IDK: ideal donor kidneys.
*p = 0.025.
**p = 0.014
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deﬁnition is associated with shorter graft survival, deteriorated function, and more frequent renal
delayed graft function. However, this did not increase the mortality of recipients.
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